RxSight (RXST) Change in Account Payables (2020 - 2026)

RxSight (RXST) has reported Change in Account Payables for 7 consecutive years, with -$631000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Account Payables rose 83.02% year-over-year to -$631000.0; the trailing twelve-month figure through Jun 2026 stood at $3.1 million (up 329.69% YoY), and the FY2025 full-year result was $627000.0, down 33.72% from the prior year.
• Change in Account Payables slipped to -$631000.0 in Q2 2026 per RXST's latest filing, from $1.6 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $2.2 million in Q1 2025 and bottomed at -$3.7 million in Q2 2025.
• Historically, Change in Account Payables has averaged $244666.7 across 5 years, with a median of $138500.0 in 2023.
• The sharpest annual moves came in 2022 and 2025: Change in Account Payables sank 1779.21% in 2022, then soared 1800.0% in 2025.
• Over 5 years, Change in Account Payables stood at -$1.7 million in 2022, then soared by 90.68% to -$158000.0 in 2023, then jumped by 173.42% to $116000.0 in 2024, then jumped by 1800.0% to $2.2 million in 2025, then tumbled by 128.63% to -$631000.0 in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$631000.0, $1.6 million, and $2.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.